Coya Therapeutics Inc (COYA) 13F Holders & Ownership Data (57 Funds, Q2 2026)

COYA ranks #5827 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

57 institutions disclose a position in COYA, but none treat it as a major bet — even CM Management, LLC, its most concentrated holder, allocates just 1.5% of its own portfolio to it.

Jim Simons has added to its COYA position for two straight quarters, increasing it by $740.9K to reach $1.1M today.

AIGH Capital Management LLC has trimmed its COYA position for two straight quarters, cutting it by $2.0M while still holding $3.7M.

COYA reported a net loss of $21.7M over the trailing twelve months.

• Not yet profitable — net loss of $21.7M over the trailing twelve months
• Revenue grew 1793.8% year over year
• Net income declined year over year, from -$20.3M to -$21.7M
• Operating cash flow was negative, using $10.7M in cash
• Current ratio of 8.50x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range